home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

822 rows where filing_year = 2011 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • fourth_quarter 211
  • first_quarter 210
  • third_quarter 204
  • second_quarter 197

issue_code 1

  • PHA · 822 ✖

filing_year 1

  • 2011 · 822 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1070772 CLAUDIA SCHLOSBERG 8489645a-77a6-4180-98bd-e8a17e5b97de 1T CLAUDIA SCHLOSBERG 318130 COVENANT PHARMACY, LLC 2011 first_quarter PHA Controlled Substances Act SENATE     0 1 2011-03-30T14:52:12.003000-04:00
1070776 CLAUDIA SCHLOSBERG 9161a140-348e-4d10-8bfc-d15e47a74997 1T CLAUDIA SCHLOSBERG 318130 FORUM EXTENDED CARE SERVICES 2011 first_quarter PHA Controlled Substances Act SENATE     0 1 2011-03-30T15:14:15.837000-04:00
1070778 CLAUDIA SCHLOSBERG b07ff490-2a7a-46b0-859e-aaa69f8a2164 1T CLAUDIA SCHLOSBERG 318130 MCNEILL'S LONG TERM CARE PHARMACY 2011 first_quarter PHA Controlled Substances Act SENATE     0 1 2011-03-30T15:20:18.120000-04:00
1070781 CLAUDIA SCHLOSBERG 1d6d570a-0b9a-4761-893c-9a40899e847d 1T CLAUDIA SCHLOSBERG 318130 PHARMACY CARE ASSOCIATES 2011 first_quarter PHA Controlled Substances Act SENATE     0 1 2011-03-30T15:26:20.437000-04:00
1070840 HOLLAND & KNIGHT LLP 2a5467c0-682e-42ca-934c-76830b9821f9 Q1 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2011 first_quarter PHA Hematology and Oncology drug research and approval issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2011-03-31T12:10:22.433000-04:00
1070850 HOLLAND & KNIGHT LLP c6b1bb39-0052-4adf-937a-7634680fc959 Q1 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2011 first_quarter PHA Blood and blood product safety; issues related to blood product approvals; Blood donor deferral policies, 340B Drug purchasing program and orphan drugs. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 40000   0 0 2011-03-31T12:14:25.840000-04:00
1070912 RED+BLUE STRATEGIES 6e10da1b-1960-4be0-94be-8bb074f3b01d Q1 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2011 first_quarter PHA Medicare and Medicaid regulations and guidance specific to drug pricing Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-04-01T12:30:20.533000-04:00
1070955 PUBLIC AFFAIRS RESOURCES, INC. 273d59ab-481c-4b57-b879-25f26ee2590c Q1 PUBLIC AFFAIRS RESOURCES, INC. 31270 PACKAGING CORPORATION OF AMERICA (PCA) (BOISE INC IS NOW A SUBSIDIARY OF PCA ) 2011 first_quarter PHA Electronic Professional Inserts in lieu of Paper, FDA Federal Reserve System,HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-01T15:40:47.960000-04:00
1071000 CYBER SECURITY RESEARCH CONSULTANTS, LLC 6e44d05b-62da-4af4-b067-92433b306596 Q1 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2011 first_quarter PHA Food and Drug Safety Globalization Act Moniitoring Dorgan-Snowe Drug Reimportation from Canada Health Care Reform HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-03T15:42:37.207000-04:00
1071172 LONG TERM CARE PHARMACY ALLIANCE 2b0f56e5-3af7-4cbc-91ca-aa21be5b5f53 Q1 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2011 first_quarter PHA Medicare Part D Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2011-04-04T14:25:48.210000-04:00
1071275 RED+BLUE STRATEGIES 06bbb87b-7249-41a7-892d-9c1d977f7cf6 Q1 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2011 first_quarter PHA Issues regarding a newly approved drug, Makena, by the FDA. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-04-05T11:07:06.350000-04:00
1071458 DUQUESNE UNIVERSITY f68b3c69-cd88-459f-8b40-8099e643991a Q1 DUQUESNE UNIVERSITY 400535603 DUQUESNE UNIVERSITY 2011 first_quarter PHA On March 31, 2011 meetings on Capitol Hill took place to discuss Duquesne University's School of Pharmacy and its various community outreach activities including the School's application to join HRSA's 340B drug pricing program, and application for a FQHC Planning Grant. Senator Casey's office agreed to send a letter of support to HRSA in support of the FQHC Planning Grant application. HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-04-06T11:00:23.663000-04:00
1071683 AMERICAN COLLEGE OF CLINICAL PHARMACY 9e2450c9-3ed9-4a74-93a0-f2f3fe0e47ea Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2011 first_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   59600 0 0 2011-04-06T15:37:20.920000-04:00
1071718 RED+BLUE STRATEGIES 0231e8ab-bb14-42e0-831d-dd51e0058c41 Q1 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2011 first_quarter PHA Issues related to upstream and downstream drug supply chain safety. Working to help develop both legislative and non-legislative movement around issues related to the development of new generations of antibiotics (bills have not yet been introduced). Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2011-04-06T16:55:40.687000-04:00
1072098 INDEPENDENT PHARMACY COOPERATIVE a283f822-b3bb-4959-84ff-7175a64a8083 Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2011 first_quarter PHA Short-Cycle dispensing of medication in long-term care facilities. CMS Proposed Rule. All provisions DEA Physician/Nurse Agent Definition. H.R. 891 The Medication Therapy Management Benefits Act of 2011. All provisions. S. 274 TheMedication Management Empowerment Act of 2011. All provisions Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2011-04-08T11:15:35.153000-04:00
1072327 PARRY, ROMANI, DECONCINI & SYMMS 1d5e90af-22f6-4352-8142-09cbad6a0fa9 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2011 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-04-08T15:22:26.917000-04:00
1072369 PARRY, ROMANI, DECONCINI & SYMMS ea00aa64-6bd2-400b-bbc9-3978c2947303 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2011 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2011-04-08T15:42:43.937000-04:00
1072651 RUBICON ADVISORS, LLC eaaf0be6-372b-489e-ae04-0cba51abeece Q1 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2011 first_quarter PHA Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-11T11:08:20.853000-04:00
1072652 RUBICON ADVISORS, LLC 44932da4-ab64-4cfe-b072-793dae6d152a Q1 RUBICON ADVISORS, LLC 315091 CHILDREN'S HOSPITAL AND RESEARCH CENTER 2011 first_quarter PHA Health Care HOUSE OF REPRESENTATIVES,SENATE 37500   0 0 2011-04-11T11:10:21.600000-04:00
1072668 RUBICON ADVISORS, LLC 5a40fb18-6f05-4ca9-a2b9-ed7b5d976583 Q1 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2011 first_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969 HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2011-04-11T11:22:30.203000-04:00
1072669 RUBICON ADVISORS, LLC 309f72d4-b02c-4a8a-979c-decf35ffe032 Q1 RUBICON ADVISORS, LLC 315091 INSMED INCORPORATED 2011 first_quarter PHA Generic Biologics S. 1695 Affordable Health Care Choices Act HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2011-04-11T11:24:31.547000-04:00
1072672 RUBICON ADVISORS, LLC fe409a2d-80ab-4f03-8a14-73251b13a21b Q1 RUBICON ADVISORS, LLC 315091 OSMOTICA PHARMACEUTICALS 2011 first_quarter PHA FDA Citizen Petition Reform Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 35000   0 0 2011-04-11T11:27:33.203000-04:00
1072676 RUBICON ADVISORS, LLC 70a31b4b-e6f6-43b3-9c5b-858f843e842f Q1 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2011 first_quarter PHA Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2011-04-11T11:29:34.903000-04:00
1072677 RUBICON ADVISORS, LLC d3eb2a2d-05ef-4cf5-92db-8baff7a4e93e Q1 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2011 first_quarter PHA Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 HOUSE OF REPRESENTATIVES,SENATE 98000   0 0 2011-04-11T11:31:35.653000-04:00
1073072 PARRY, ROMANI, DECONCINI & SYMMS ad6c9940-589e-4b04-bf56-340f4b6859e3 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2011 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-04-11T17:00:42.850000-04:00
1073088 PARRY, ROMANI, DECONCINI & SYMMS 4e1ae626-592c-4b9b-a1c8-114ed5a5372d Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2011 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11508   0 0 2011-04-11T17:13:52.467000-04:00
1073102 PARRY, ROMANI, DECONCINI & SYMMS b5c58240-d691-49bb-aced-f39da99456b5 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2011 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-04-11T17:24:59.107000-04:00
1073390 WHITMER & WORRALL, LLC d7542f8c-9973-49d6-8048-a588509a2220 Q1 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2011 first_quarter PHA Issues related to monitoring healthcare reform. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-12T11:12:24.323000-04:00
1073736 POLICY DIRECTIONS INC. dd48e01b-1ad2-4e80-82a8-ff8914bf619a Q1 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2011 first_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. Efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-12T15:06:37.427000-04:00
1073892 PD FRAZER CONSULTING, INC. 47fe36d7-8e2e-4134-a82e-150a5be2a457 Q1 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2011 first_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-04-12T15:52:03.213000-04:00
1074018 THE RUSSELL GROUP, INC. d3b965b1-a080-4f90-a53c-a5256973bd58 Q1 THE RUSSELL GROUP, INC. 22688 GENERIC PHARMACEUTICAL ASSOCIATION 2011 first_quarter PHA Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011). HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 40000   0 0 2011-04-12T17:20:17.393000-04:00
1074209 UPS (UNITED PARCEL SERVICE) f88c4d40-112b-4747-9cb3-441c812c2f5e Q1 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2011 first_quarter PHA - Pedigree Track and Trace - HHS/CDC PEPFAR Grant for Supply Commerce, Dept of (DOC),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,Small Business Administration (SBA),State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR)   1572401 0 0 2011-04-13T10:28:07.153000-04:00
1074440 THE MATHIS HARPLE GROUP 2d34eecc-1125-4f59-9af7-33e0077741c3 Q1 THE MATHIS HARPLE GROUP 322911 PILMA 2011 first_quarter PHA Health Care legislation HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-13T12:47:14.983000-04:00
1075041 GOVBIZ ADVANTAGE, INC. 0b77fcdf-fc0d-4d57-98fd-86157a276aaf Q1 GOVBIZ ADVANTAGE, INC. 294234 CATALYST HEALTH SOLUTIONS (CATAMARANRX) 2011 first_quarter PHA Pharmacy Benefit Issues in health legislation; PBA issues; General company congressional relations; business issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-13T17:44:06.733000-04:00
1075414 MEREDITH MCGEHEE c61871d8-5cbc-4a46-8a98-ff18bd02c489 Q1 MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2011 first_quarter PHA Funding for programs to develop AIDS vaccines targeted toward the developing world; Working with Global Health Technologies Coalition to educate on research and development programs aimed at the AIDS epidemic and other health issues; Implementation of PEPFAR and appropriations for USAID R&D and funding for IAVI; Provide information on IAVI's model; Providing input of foreign assistance reform from a global health perspective; funding and budget issues as related to USAID. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-14T10:46:06.453000-04:00
1075509 MCDERMOTT WILL & SCHULTE LLP 3742efae-1c2c-4863-bdb4-a9a3cf36a934 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2011 first_quarter PHA Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-14T11:17:24.677000-04:00
1075635 BUCHANAN INGERSOLL & ROONEY PC 04856c1a-4e24-4710-84ee-d1bb31393fb6 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 SHIRE PHARMACEUTICALS INC 2011 first_quarter PHA Life Sciences investment Act; Creating Hope Act; Pharma fees and orphan drug exclusion; ESRD bundling of non-injectable oral equivalents, ESRD Quality Incentive program; orphan drugs; health care reform implementation; ADHD awareness Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-04-14T11:49:18.457000-04:00
1076191 DUTKO WORLDWIDE, LLC 46566eca-56f1-4d4a-ba4a-30cb72738262 Q1 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2011 first_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-14T15:35:24.010000-04:00
1076590 WINBORN SOLUTIONS LLC 3a4c38cd-7dc2-47b7-aac1-33e314ae13d5 Q1 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2011 first_quarter PHA Generic drug user fee legislation HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2011-04-14T20:22:13.263000-04:00
1076639 AMERICA'S ESSENTIAL HOSPITALS 88a8c366-5c33-4ea0-9345-c76beb31187e Q1 AMERICA'S ESSENTIAL HOSPITALS 27057 AMERICA'S ESSENTIAL HOSPITALS 2011 first_quarter PHA Request that stakeholders be permitted to review and comment on (i) Notice Regarding Section 602 of the Veterans Health Care Act of 1992 Definition of "Patient" (RIN: 0906-ZA08) and (ii) Notice Regarding Section 602 of the Veterans Health Care Act of 1992 Definition of "Patient" - Withdrawl of Previous Notice (RIN: 0906-ZA09) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   190000 0 0 2011-04-15T09:11:46.180000-04:00
1076755 MCDERMOTT WILL & SCHULTE LLP 4e788be5-d061-4e93-9728-8aee0af040ea Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2011 first_quarter PHA Issues related to Section 340B of the Public Health Service Act. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-15T10:28:49.257000-04:00
1076851 MCDERMOTT WILL & SCHULTE LLP dca9390b-6c6f-40b6-a274-e037ca5243b8 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2011 first_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-15T11:11:43.990000-04:00
1077190 HANCE SCARBOROUGH 328ad9e4-23e5-42d1-895e-c9a4ed2527d7 Q1 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2011 first_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-15T13:25:28.713000-04:00
1077213 HANCE SCARBOROUGH c6c112e7-90e9-46e2-8697-4b1797d1faf0 Q1 HANCE SCARBOROUGH 17443 TEXAS ACADEMY OF COMPOUNDING PHARMACISTS 2011 first_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-15T13:33:42.913000-04:00
1077332 EVERTZ GROUP LLC b6901ea7-c12e-4feb-9e18-bb660109c71f Q1 EVERTZ GROUP LLC 400497446 MYLAN INC. 2011 first_quarter PHA Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) 30000   0 0 2011-04-15T14:24:49.220000-04:00
1077430 AARP 7105b1a3-761e-4e04-ac2b-684601fedec3 Q1 AARP 1694 AARP 2011 first_quarter PHA H.J. Res. 44, H.J. 48, Continuing Appropriations Amendments, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance. Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed importance of potential savings to consumers through safe importation of prescription drugs and endorsed legislation. Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. Administration on Aging,Agriculture, Dept of (USDA),Bureau of the Census,Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Equal Employment Opportunity Commission (EEOC),Federal Communications Commission (FCC),Federal Energy Regulatory Commission (FERC),Federal Reserve System,Federal Transit Administration (FTA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Highway Traffic Safety Administration (NHTSA),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   5000000 0 0 2011-04-15T14:49:02.477000-04:00
1077609 WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC 49b1d5b7-e605-4690-af58-04b909197e2d Q1 WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC 41113 JARROW FORMULAS, INC. 2011 first_quarter PHA Federal food safety legislation affecting dietary supplements, and concerning Codex Alimentarius; and the Dietary Supplement Health and Education Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-15T15:16:34.697000-04:00
1077808 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 44d79e57-d2f7-4609-a9ce-ed20d5c9f3ad Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2011 first_quarter PHA Importation of prescription drugs (S.319, H.R. 147); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation; NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065); Drug Abuse (S. 507); Drug Shortages (S. 296) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   232000 0 0 2011-04-15T15:48:14.107000-04:00
1078139 BGR GOVERNMENT AFFAIRS c05088c1-46ba-4373-a93e-57df0e85b194 Q1 BGR GOVERNMENT AFFAIRS 5357 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2011 first_quarter PHA Counsel and guidance on legislative or regulatory activity that could affect the pharmaceutical industry Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-15T17:28:07.783000-04:00
1078390 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC a73dcd48-f20e-4706-8ea2-df87739e4722 Q1 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 WOCKHARDT USA LLC 2011 first_quarter PHA Preemption for ANDA holders under FDA Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-16T08:29:12.280000-04:00
1078394 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 0636085b-3f16-4746-92d8-8dbc964c0e66 Q1 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 TEVA PHARMACUETICALS USA 2011 first_quarter PHA Proposals to limit settlements between ANDA and NDA holders in Hatch-Waxman litigation HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-16T08:42:15.667000-04:00
1078878 THE OB-C GROUP, LLC 5bc24748-b37f-4c42-9207-1eb387c7f032 Q1 THE OB-C GROUP, LLC 29802 ELI LILLY 2011 first_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-18T09:20:49.470000-04:00
1079086 NATIONAL RETIREE LEGISLATIVE NETWORK 23a8bf58-2f7b-4c96-ba87-42e125fe31b7 Q1 NATIONAL RETIREE LEGISLATIVE NETWORK 400559672 NATIONAL RETIREE LEGISLATIVE NETWORK 2011 first_quarter PHA Pharmaceutical costs. HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   15000 0 0 2011-04-18T10:05:34.223000-04:00
1079558 BLUECROSS BLUESHIELD OF TENNESSEE 3ead8ecb-ce5c-4ce1-bf22-dbe552994ab6 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2011 first_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2011-04-18T11:12:39.557000-04:00
1079703 VENABLE LLP 4f76a6fb-7f82-4444-88b4-32dd962354e7 Q1 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2011 first_quarter PHA General issues affecting the pharmaceutical industry The Life Sciences Investment Act HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-04-18T11:35:56.630000-04:00
1079727 C2 GROUP, LLC d5465b61-6b33-4292-94ce-494edacdd023 Q1 C2 GROUP, LLC 66693 PERRIGO INC 2011 first_quarter PHA FSA Changes; Drug Regulation; FDA Reform; PDUFA HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-18T11:40:58.127000-04:00
1080581 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 788cce9c-f954-4c3a-8812-3572c96d9bae Q1 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 309377 ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 2011 first_quarter PHA Support legislation that would allow independent pharmacies to collectively negotiate contracts with prescription drug plans and health insurance plans. HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-04-18T14:07:58.467000-04:00
1080603 JULIE PHILP ab5a9ede-e3e2-4f2d-b518-cbd37b20830b Q1 JULIE PHILP 400407928 NATIONAL GRASSROOTS AND COMMUNICATION 2011 first_quarter PHA Support legislation that would allow independent pharmacies to collectively negotiate contracts with prescription drug plans and health insurance plans. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-18T14:11:13.650000-04:00
1080631 TARPLIN, DOWNS & YOUNG, LLC ffb5411d-3e85-42b7-8dd0-506010b70e26 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2011 first_quarter PHA **see addendum page Importation of prescription drugs (S.319/H.R. 147) Methamphetamine/Pseudoephedrine Regulation NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065) Drug Abuse (S. 507) Drug Stortages (S. 296) no specific bills, federal pedigree, import safety Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-04-18T14:13:27.433000-04:00
1080636 SMITH GARSON FKA SMITH DAWSON & ANDREWS 856f201e-1504-4141-a34c-7a6352cf0a67 Q1 SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 PROSETTA CORPORATION 2011 first_quarter PHA Government Advertisement of Biopharmaceuticals       0 0 2011-04-18T14:13:30.230000-04:00
1080716 SMITH GARSON FKA SMITH DAWSON & ANDREWS 16911756-b6ce-4b77-809d-24190202a373 Q1 SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 STRUVE SWINE TECHNOLOGIES 2011 first_quarter PHA Government Advertisement of Biopharmaceuticals HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-04-18T14:23:14.263000-04:00
1081056 UNIVERSITY OF CONNECTICUT cc6e6c20-595d-4d3a-a3d2-eccb79d11fcf Q1 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2011 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012, FDA salaries and expenses; and extramural research related issues. HR1, Full-Year Continuing Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2011-04-18T14:56:32.593000-04:00
1081159 ASSOCIATION OF NATIONAL ADVERTISERS, INC. efefa0b1-4c30-4404-bbd7-c38328bbb4a5 Q1 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2011 first_quarter PHA Proposals to require a "fair balance" between risk and benefit information in prescription drug advertisements Proposals to change the requirements for the "major statement" in direct to consumer prescription drug advertisements Commerce, Dept of (DOC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   260000 0 0 2011-04-18T15:08:33.107000-04:00
1081585 AKIN GUMP STRAUSS HAUER & FELD eb9f27fb-a362-479e-9f51-bb3acf22383f Q1 AKIN GUMP STRAUSS HAUER & FELD 682 PRASCO, INC. 2011 first_quarter PHA Promoting consumer benefits of authorizd generic drugs Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2011-04-18T16:06:24.873000-04:00
1081824 EMPIRE CONSULTING GROUP 6b82244c-5d23-4749-80da-698b874925ea Q1 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2011 first_quarter PHA Diabetes education and awareness in minority communities; patent reform proposals HOUSE OF REPRESENTATIVES 30000   0 0 2011-04-18T16:44:34.153000-04:00
1081943 MARSHFIELD CLINIC HEALTH SYSTEM 7a581052-325b-48b2-87d6-0dfe6930f376 Q1 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2011 first_quarter PHA Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine. In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE   130000 0 0 2011-04-18T17:00:40.887000-04:00
1082217 EXPRESS SCRIPTS, INC. fbb7ec00-0a8c-40fe-8084-529214fdc79a Q1 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2011 first_quarter PHA Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (essential health benefits, grandfathering, value-base insurance design, Rx quality, electronic prescribing, PBM disclosure requirements, medical loss ratio); legislation to promote generic drugs; regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; Zadroga implement. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,White House Office   490000 0 0 2011-04-18T17:38:58.027000-04:00
1082296 MR. MATTHEW R. SIMMONS 849163f3-1873-497e-9784-3a677f894be8 Q1 MR. MATTHEW R. SIMMONS 400458211 NATIONAL COALITION OF PHARMACEUTICAL DISTRIBUTORS 2011 first_quarter PHA PDMA reform; general pharmaceutical distribution policy Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-18T17:50:34.703000-04:00
1082398 TARPLIN, DOWNS & YOUNG, LLC 476ec097-db0f-44f5-9d8e-e09deb3c8474 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2011 first_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act ***, no specific bill(s), prescription drug importation, import safety HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-04-18T18:06:20.087000-04:00
1082425 TARPLIN, DOWNS & YOUNG, LLC 193dc716-f4b7-4d09-b1ee-be8389cb5a0d Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2011 first_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2011-04-18T18:10:29.963000-04:00
1082431 TARPLIN, DOWNS & YOUNG, LLC d7195a97-4f91-4e0a-a7a0-52739b6094af Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2011 first_quarter PHA **see addendum page **, no specific bill(s), Import Safety Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-18T18:12:33.480000-04:00
1083330 SQUIRE PATTON BOGGS b7c7c14a-31d7-4a90-b385-af9f1d04b954 Q1 SQUIRE PATTON BOGGS 30906 KV PHARMACEUTICAL COMPANY 2011 first_quarter PHA Prescription drug coverage and pricing for progesterone injection. HOUSE OF REPRESENTATIVES,SENATE 180000   0 0 2011-04-19T09:12:32.317000-04:00
1083536 SQUIRE PATTON BOGGS dc2a868f-49a3-4222-a3bb-f112ac13eb01 Q1 SQUIRE PATTON BOGGS 30906 RANBAXY INC. 2011 first_quarter PHA S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; H.R. 4, Comprehensive 1099 Taxpayer Protection and Repaymentof Exchange Subsidy Overpayments Act; S. 23, the America Invents Act; H.R. 1, Full Year Continuing Appropriations Act. HOUSE OF REPRESENTATIVES,SENATE 160000   0 0 2011-04-19T09:51:30.223000-04:00
1084424 LOCKE LORD PUBLIC POLICY GROUP LLC 582359fc-d2bf-4df5-a09e-feeeb829d159 Q1 LOCKE LORD PUBLIC POLICY GROUP LLC 300971 MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES 2011 first_quarter PHA Pharmaceutical performance reimbursement; biogenics HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-19T11:23:22.110000-04:00
1084436 POWERS PYLES SUTTER & VERVILLE, P.C. cffe4441-d18b-4365-8d6b-1a0cf214d8a7 Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 340B HEALTH 2011 first_quarter PHA Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Veterans Affairs, Dept of (VA) 45000   0 0 2011-04-19T11:23:27.267000-04:00
1084705 ACADEMY OF MANAGED CARE PHARMACY 09c50b2b-2e32-43b1-81b9-0b03cbb8fc2c Q1 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2011 first_quarter PHA Legislation relating to pharmacy issues and the professional role of pharmacists, legislation relating to medication therapy management programs and funding for such programs, legislation relating to the importation of prescription drugs, legislation relating to settlement agreements between brand-name and generic manufacturers, legislation promoting the use of generic drugs generally, legislation relating to pharmacy benefit managers HOUSE OF REPRESENTATIVES,SENATE   178000 0 0 2011-04-19T11:49:42.250000-04:00
1084881 C2 GROUP, LLC 32b51b97-b75e-4a54-96dd-d2c56aae1c0d 1A C2 GROUP, LLC 66693 PERRIGO INC 2011 first_quarter PHA FSA Changes, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA Reform; PDUFA HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-19T12:07:23.500000-04:00
1084898 INDEPENDENCE BLUE CROSS 4827203c-da1c-45ea-81f0-891e1e6f276e Q1 INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2011 first_quarter PHA FEHBP Pharmacy Benefits Contracting HOUSE OF REPRESENTATIVES,SENATE,White House Office     0 0 2011-04-19T12:10:16.303000-04:00
1084986 CAPITOL HILL CONSULTING GROUP a754da70-abb6-4e52-9a19-d220be00e871 Q1 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2011 first_quarter PHA Controlled Drug Substances Act (21 USC 13) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-19T12:22:06.247000-04:00
1085122 UNIVERSITY OF IOWA ad845130-52b9-4a16-b94e-19411b0e4add Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2011 first_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2011-04-19T12:35:12.370000-04:00
1085263 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS b2b6db64-e2a6-4c39-93ff-c5f016c40a59 Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2011 first_quarter PHA Communication to Surgeon General on recognition of pharmacists as health care providers. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2011-04-19T12:46:14.373000-04:00
1085762 AMERICAN PHARMACISTS ASSOCIATION 8ed6768a-c97a-47ae-a0ad-178359dd5b01 Q1 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2011 first_quarter PHA Pharmacist Loan Repayment Eligibility Act of 2011 (S.48) (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number: FDA-2010-N-0128) Prescription Drug User Fee Act; Reopening of the Comment Period (Docket Number: FDA-2010-N-0001) Third Annual Sentinel Initiative Public Workshop (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: FDA-2011-D-0074-0001) Draft Guidance for Industry on Medication Guides; Availability: Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies; Availability (Docket Number: FDA-2010-N-0633) Determination of System Attributes for Tracking and Tracing of Prescription Drugs; Public Workshop (Docket Number: DEA316N) Procedures for the Surrender of Unwanted Controlled Substances by Ultimate Users; Notice of Meeting (Docket Number: FDA2011N0100) Drugs for Human Use; Unapproved and Misbranded Oral Drugs Labeled for Prescription Use and Offered for Relief of Symptoms of Cold, Cough, or Alergy; Enforcement Action Dates (Docket Number: FDA-2011-N-0002) Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee; Notice of Meeting Concept - Standardizing REMS programs, components and development of a potential tiered REMS System Concept - Designing Pilot Programs to Distribute Patient Medication Information Concept - Drug Disposal Concept - Preventing counterfeit prescription drugs from entering the supply chain Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   187231 0 0 2011-04-19T13:40:18.277000-04:00
1086300 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 69980c3b-4cb4-42d1-8495-2c628882d6e9 Q1 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2011 first_quarter PHA S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE   660000 0 0 2011-04-19T14:31:48.917000-04:00
1086351 AMERICAN ADVERTISING FEDERATION 311af5b8-9068-4e72-9f20-72d6eb471e70 Q1 AMERICAN ADVERTISING FEDERATION 1411 AMERICAN ADVERTISING FEDERATION 2011 first_quarter PHA Proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals Proposals to require a moratorium on the advertising of new prescription medicines Proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   41000 0 0 2011-04-19T14:35:09.180000-04:00
1086761 WALGREEN COMPANY c63ee7a1-457d-4d63-90c3-be696c6d4b32 Q1 WALGREEN COMPANY 309071 WALGREEN COMPANY 2011 first_quarter PHA Drug safety-no specific legislation-regarding any discussions surrounding the security of the drug supply chain. HOUSE OF REPRESENTATIVES,SENATE   530000 0 0 2011-04-19T15:09:35.227000-04:00
1086815 MASSACHUSETTS MEDICAL SOCIETY cb8f4d3a-eae2-4dcf-8488-88da1ab6a028 Q1 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2011 first_quarter PHA CMS: Open Door Forum Comments on Transparency Reports and Reporting of Physician Ownership or Investment Issues Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE   90000 0 0 2011-04-19T15:12:52.757000-04:00
1087177 BROWN RUDNICK LLP 7bed8248-ed8a-4b8d-b62c-11d08d4affb9 Q1 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2011 first_quarter PHA Issues related to supply chain safety and drug theft; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; S. 296 - Preserving Access to Life-Saving Medication Act of 2011 HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-19T15:41:34.790000-04:00
1087201 THORN RUN PARTNERS e704e8f7-e7b0-48a6-a7f8-883775fd16ec Q1 THORN RUN PARTNERS 400534596 LONG TERM CARE PHARMACY ALLIANCE 2011 first_quarter PHA Issues related to the implementation of the Affordable Care Act (ACA). Issues related to DEA enforcement of controlled substances in nursing homes. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-19T15:43:44.913000-04:00
1087473 340B HEALTH ba471477-44e4-4c6c-b844-61c719c7113f Q1 340B HEALTH 316434 340B HEALTH 2011 first_quarter PHA Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   218868 0 0 2011-04-19T16:05:48.770000-04:00
1087912 GREATER NEW YORK HOSPITAL ASSOCIATION 159f4423-405e-40d7-b9d9-9cf349daf94a Q1 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2011 first_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296), and preserving access to group purchasing organizations. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   380000 0 0 2011-04-19T16:41:48.310000-04:00
1088781 BATES CAPITOL GROUP, INC. 53bcf7be-8449-488a-aeec-8c62141b73f9 Q1 BATES CAPITOL GROUP, INC. 400656969 C2 GROUP (ON BEHALF OF BIOTECHNOLOGY INDUSTRY ORGANIZATION) 2011 first_quarter PHA Support strong and fully funded FDA review process. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-19T18:23:03.623000-04:00
1088959 PODESTA GROUP, INC. d5c1beca-b7b5-4735-87d5-f3d2c9c6fda0 Q1 PODESTA GROUP, INC. 31680 AMGEN 2011 first_quarter PHA Prescription Drug User Fee Act reauthorization. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-04-19T19:05:40.837000-04:00
1089078 PODESTA GROUP, INC. af9e0e98-fe47-47e9-93f2-d325b86be1d6 Q1 PODESTA GROUP, INC. 31680 COVIDIEN 2011 first_quarter PHA Issues involving controlled substances and pain and addiction drugs generally. Issues related to acetaminophen. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-19T19:28:34.357000-04:00
1089120 PODESTA GROUP, INC. 96c6cbad-5bf5-4546-8f13-96321b701220 Q1 PODESTA GROUP, INC. 31680 EISAI INC. 2011 first_quarter PHA Drug issues, generally. Prescription Drug User Fee Act reauthorization. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-04-19T19:42:51.977000-04:00
1089132 WINSTON & STRAWN LLP ddf3373f-3b0e-41dd-8528-8089053de2d5 Q1 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2011 first_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters, including settlements. Legislation of interest includes the FY 2011 Financial Services Appropriations Bill (S. 3677), the FY 2010 Supplemental Appropriations Bill (H.R. 4899; P.L. 111-212), and the Continuing Appropriations and Surface Transportation Extensions Act, 2011 (H.R. 3082; P.L. 111-322). HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-04-19T19:48:59.320000-04:00
1089204 DLA PIPER LLP (US) 5798c4ff-eaaf-4276-bb01-872ea147f90b Q1 DLA PIPER LLP (US) 76855 SANOFI PASTEUR 2011 first_quarter PHA Pandemic influenza, vaccine-related issues. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-04-19T20:15:45.150000-04:00
1089245 PODESTA GROUP, INC. ebd8976a-7475-4ec9-8691-99fd5037480e Q1 PODESTA GROUP, INC. 31680 NOVO NORDISK INC 2011 first_quarter PHA Prescription Drug User Fee Act reauthorization. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-04-19T20:30:05.260000-04:00
1089251 WINSTON & STRAWN LLP a08338f0-d47e-499e-b1e4-40049e8af3bc Q1 WINSTON & STRAWN LLP 41682 WOCKHARDT USA LLC 2011 first_quarter PHA Generic drug issues - preemption; FTC settlements HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-04-19T20:34:07.900000-04:00
1089342 THE INGRAM GROUP LLC 329aeb87-bb45-45e7-8b9f-aa038de318b7 Q1 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2011 first_quarter PHA Issues related to the Patient Protection and Affordable Care Act: Medicare payment issues including the Independent Payment Advisory Board (IPAB) and S.23, Patent Reform Act of 2011. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-04-19T21:02:54.710000-04:00
1089428 WALMART INC. dc908053-d8cd-49e4-9cea-97f2a9cb79e3 Q1 WALMART INC. 40305 WALMART INC 2011 first_quarter PHA Discussions regarding generic drugs (no bill) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Environmental Protection Agency (EPA),Federal Trade Commission (FTC),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Securities & Exchange Commission (SEC),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Trade Representative (USTR),White House Office   2390000 0 0 2011-04-19T21:31:34.820000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1412.456ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API